Article ID Journal Published Year Pages File Type
8735170 Transfusion Medicine Reviews 2018 28 Pages PDF
Abstract
Our data suggest that patients who developed AIHA after HSCT are severely lymphopenic and have a high risk of mortality. Outcome is better in children and in patients treated with rituximab. We also propose an algorithm for treatment of AIHA after HSCT.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Hematology
Preview
Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Españo
Authors
, , , , , , , , , , , , , ,